Drive Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Sell
8,612
-69
-0.8% -$1.8K 0.04% 423
2026
Q1
$244K Buy
+8,681
New +$231K 0.05% 300
2025
Q1
Sell
-10,177
Closed -$270K 369
2024
Q4
$270K Sell
10,177
-1,829
-15% -$49.6K 0.07% 237
2024
Q3
$347K Sell
12,006
-8,590
-42% -$251K 0.09% 186
2024
Q2
$576K Buy
20,596
+4,925
+31% +$136K 0.16% 112
2024
Q1
$435K Sell
15,671
-5,719
-27% -$159K 0.12% 153
2023
Q4
$616K Sell
21,390
-3,133
-13% -$94.7K 0.2% 103
2023
Q3
$813K Buy
24,523
+2,019
+9% +$71.4K 0.3% 73
2023
Q2
$825K Buy
22,504
+1,271
+6% +$49.5K 0.31% 73
2023
Q1
$866K Buy
21,233
+10,154
+92% +$439K 0.36% 64
2022
Q4
$568K Sell
11,079
-4,554
-29% -$218K 0.28% 85
2022
Q3
$684K Buy
15,633
+9,050
+137% +$440K 0.65% 35
2022
Q2
$345K Buy
6,583
+830
+14% +$42.3K 0.32% 100
2022
Q1
$298K Buy
5,753
+165
+3% +$8.56K 0.25% 103
2021
Q4
$330K Buy
+5,588
New +$277K 0.29% 92

Other funds holding PFE

Drive Wealth Management's PFE Position: Q2 2026 in Review

Drive Wealth Management reduced its Pfizer (PFE) stake by 0.79% in Q2 2026, selling an estimated $1.8K and leaving 8,612 shares worth $207K. The position accounts for 0.04% of the portfolio, ranked #423.

Drive Wealth Management first reported a position in PFE in Q4 2021 and has held it in 15 quarters since. The position peaked at $866K in Q1 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Drive Wealth Management held 8,612 shares of Pfizer worth $207K as of Q2 2026.
  • Drive Wealth Management sold 69 Pfizer shares in Q2 2026, an estimated $1.8K.
  • Pfizer made up 0.04% of Drive Wealth Management's portfolio in Q2 2026, its #423 holding.
  • Drive Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 15 quarters since.
  • Drive Wealth Management's Pfizer position peaked at $866K in Q1 2023.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.